1. Evaluation of imatinib mesylate (Gleevec) on KAI1/CD82 gene expression in breast cancer MCF-7 cells using quantitative real-time PCR
Seyed Ataollah Sadat SHANDIZ ; Amir MIRZAIE ; Hamidreza JOUZAGHKAR ; Marjan KHOSRAVANI ; Sepideh MOHAMMADI ; Hassan NOORBAZARGAN ; Davoud Nouri INANLOU ; Mojgan Dalirsaber JALALI ; Fahimeh BAGHBANI-ARANI ; Behta KESHAVARZ-PAKSERESHT
Asian Pacific Journal of Tropical Biomedicine 2016;6(2):159-163
Objective: To evaluate the effect of imatinib mesylate on cell viability, anti cancer effect through modulation of KAI1/CD82 gene expression in breast cancer MCF-7 cell line. Methods: The effects of imatinib mesylate on cell viability in MCF-7 cell line were assessed using MTT assay and IC
Result Analysis
Print
Save
E-mail